(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THORACOFLEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THORACOFLEX

ST13

US500000079231501

Class

10

Filing

79231501

Registration

5777996

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

01/27/2026

Trademark type

Word

Nice classes

10

Filing date

10/31/2017

Registration date

06/18/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/02/2026

Last transaction

01/27/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

24

Owner location

GB

Examiner

SAITO, KIM

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vascutek Limited

Representatives

Thomas W. Cole RobertsMlotkowskiSafranCole&CalderonPC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Surgical apparatus and instruments; medical apparatussynthetic medical vascular stent graftssynthetic thoracicthoracoabdominal and abdominal stent grafts; synthetic vascular grafts; stents; drug delivery patches sold without medication; vascular prostheses; surgical implants comprised of artificial materials; suture materialspatches for repair and reconstruction of internal tissue; implantable medical systems comprised of synthetic endovascular stent grafts; implantable medical devices namelysynthetic endovascular stent grafts; artificial vascular grafts; artificial endovascular grafts; surgical graft materials namelyartificial endovascular graftsartificial endovascular grafts; medical systemssystem for use in artificial organ support; medical devices for measuring blood sugar for medical purposes; medical apparatus and instruments for use in endovascular procedures; medical thoracic stents; medical thoracoabdominal stents; synthetic thoracic stent grafts; synthetic thoracoabdominal stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of medical stent grafts and stent delivery systems; stent graft devices comprised of synthetic medical stent grafts and stent delivery systems; stent graft systems and devices comprising more than one componentartificial endovascular grafts; stent graft systems and devices comprising components of more than one stent graftartificial endovascular grafts; stent graft systems and devices comprising components of more than one type of stent graftartificial endovascular graftsstent delivery systems and synthetic stent grafts; thoracic stent graft systemsartificial endovascular grafts stent delivery systems and synthetic stent grafts; thoracic stent graft devicesartificial endovascular graftsstent delivery systems and synthetic stent grafts; thoracoabdominal stent graft systemsartificial endovascular grafts stent delivery systems and synthetic stent grafts; thoracoabdominal stent graft devicesartificial endovascular graftsstent delivery systems and synthetic stent grafts; delivery systems for stent graft systems and stent graft devices; medical devicesminimally invasive devices for abdominal aortic aneurysms repair; cardiac valves for surgical prostheses; cardiac valve replacement systems comprised of artificial cardiac heart valves; medical apparatus for treating congestive heart failureheart valve conduits; structural parts and fittings for all of the aforementioned goods

Publications

History of USPTO decisions and trademark events.

30 publications found

C71T

CANCELLED SECTION 71

01/02/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/18/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/11/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/25/2019

FIMP

FINAL DISPOSITION PROCESSED

09/25/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/18/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

06/18/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/02/2019

PUBO

PUBLISHED FOR OPPOSITION

04/02/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/13/2019

ALIE

ASSIGNED TO LIE

02/25/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/08/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

02/08/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/08/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

02/08/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/08/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/19/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/19/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/19/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/19/2018

RFNP

REFUSAL PROCESSED BY IB

06/09/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/19/2018

RFRR

REFUSAL PROCESSED BY MPU

05/19/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/17/2018

CNRT

NON-FINAL ACTION WRITTEN

05/16/2018

MAFR

APPLICATION FILING RECEIPT MAILED

05/15/2018

DOCK

ASSIGNED TO EXAMINER

05/11/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/11/2018

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

05/10/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/10/2018

Continuous trademark protection

Get notified about every new filing that threatens THORACOFLEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.